I found this interesting. A purchase on the ASX and CXA of $3.38...

I found this interesting. A purchase on the ASX and CXA of $3.38 to effectively drop the share price from 6.9 cents to 6.5 cents. I assume some entity is trying to keep the share price down to accumulate cheap shares.

Looking at the latest options on offer, I think the company expects to validate the Felix device, have first commercial sales and with the share price north of 10 cents by September. Memphasys will then capital raise in February, at a higher share price then the current price. I have been buying more as If everything goes as the company plans I do not think this current opportunity will last long.